Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $856M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,428,072 | $104M | 12.2% | $24.99 | — | COM | N5749R100 |
| VERA | VERA THERAPEUTICS INC | 5,450,000 | $74.72M | 8.7% | $8.35 | +105.4% | CL A | 92337R101 |
| XENE | XENON PHARMACEUTICALS INC | 1,845,000 | $63.03M | 7.4% | $26.06 | +43.5% | COM | 98420N105 |
| PCVX | VAXCYTE INC | 1,100,000 | $56.08M | 6.6% | $46.14 | +6.9% | COM | 92243G108 |
| COGT | COGENT BIOSCIENCES INC | 5,566,026 | $54.27M | 6.3% | $8.92 | +32.9% | COM | 19240Q201 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,075,000 | $47.57M | 5.6% | $22.39 | 0.0% | COM | 76243J105 |
| — | AMBRX BIOPHARMA INC | 3,518,556 | $40.46M | 4.7% | $9.17 | — | SPONSORED ADS | 02290A102 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,901,816 | $39.64M | 4.6% | $19.64 | -14.3% | COM | 29337E102 |
| CABA | CABALETTA BIO INC | 2,525,753 | $38.44M | 4.5% | $7.66 | +78.5% | COM | 12674W109 |
| IMVT | IMMUNOVANT INC | 1,000,000 | $38.39M | 4.5% | $14.46 | +56.4% | COM | 45258J102 |
| NUVL | NUVALENT INC | 828,778 | $38.1M | 4.5% | $28.77 | +54.3% | COM | 670703107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,200,000 | $33.75M | 3.9% | $17.59 | +8.5% | COM | 92790C104 |
| — | AKERO THERAPEUTICS INC | 565,000 | $28.58M | 3.3% | $41.36 | — | COM | 00973Y108 |
| SLNO | SOLENO THERAPEUTICS INC | 887,500 | $26.19M | 3.1% | $6.05 | 0.0% | COM | 834203309 |
| IDYA | IDEAYA BIOSCIENCES INC | 775,000 | $20.91M | 2.4% | $20.56 | +23.3% | COM | 45166A102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 706,665 | $19.45M | 2.3% | $31.10 | +0.8% | COM NEW | 15117B202 |
| CELC | CELCUITY INC | 1,694,141 | $15.48M | 1.8% | $18.50 | -46.8% | COM | 15102K100 |
| — | ALPINE IMMUNE SCIENCES INC | 1,325,000 | $15.17M | 1.8% | $7.20 | — | COM | 02083G100 |
| — | ADVERUM BIOTECHNOLOGIES INC | 10,000,000 | $15M | 1.8% | $1.15 | — | COM | 00773U108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 500,000 | $14.87M | 1.7% | $20.61 | 0.0% | COM | 22663K107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 957,509 | $13.9M | 1.6% | $22.61 | -16.3% | COM | 87164F105 |
| KURA | KURA ONCOLOGY INC | 1,400,000 | $12.77M | 1.5% | $13.92 | -27.1% | COM | 50127T109 |
| — | THIRD HARMONIC BIO INC | 1,700,000 | $10.86M | 1.3% | $13.74 | — | COM | 88427A107 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 739,661 | $9.076M | 1.1% | $10.33 | +26.3% | COM | 23954D109 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,575,000 | $8.253M | 1.0% | $4.44 | 0.0% | COM | 92840H400 |
| — | RAYZEBIO INC | 288,911 | $6.414M | 0.7% | $22.20 | — | COM | 75525N107 |
| APGE | APOGEE THERAPEUTICS INC | 250,000 | $5.325M | 0.6% | $22.03 | 0.0% | COM | 03770N101 |
| — | MERSANA THERAPEUTICS INC | 2,244,378 | $2.85M | 0.3% | $1.27 | — | COM | 59045L106 |
| SYRE | AEGLEA BIOTHERAPEUTICS INC | 116,324 | $1.425M | 0.2% | $13.22 | 0.0% | COM NEW | 00773J202 |
| — | DBV TECHNOLOGIES S A | 92,687 | $126K | 0.0% | $1.53 | — | SPONSORED ADR | 23306J101 |